154 related articles for article (PubMed ID: 37948991)
1. Advances in the roles of ATF4 in osteoporosis.
Xiao Y; Xie X; Chen Z; Yin G; Kong W; Zhou J
Biomed Pharmacother; 2023 Dec; 169():115864. PubMed ID: 37948991
[TBL] [Abstract][Full Text] [Related]
2. Runt-related transcription factor 1 is required for murine osteoblast differentiation and bone formation.
Tang J; Xie J; Chen W; Tang C; Wu J; Wang Y; Zhou XD; Zhou HD; Li YP
J Biol Chem; 2020 Aug; 295(33):11669-11681. PubMed ID: 32571873
[TBL] [Abstract][Full Text] [Related]
3. Endoplasmic reticulum stress response mediated by the PERK-eIF2(alpha)-ATF4 pathway is involved in osteoblast differentiation induced by BMP2.
Saito A; Ochiai K; Kondo S; Tsumagari K; Murakami T; Cavener DR; Imaizumi K
J Biol Chem; 2011 Feb; 286(6):4809-18. PubMed ID: 21135100
[TBL] [Abstract][Full Text] [Related]
4. The PERK-EIF2α-ATF4 signaling branch regulates osteoblast differentiation and proliferation by PTH.
Zhang K; Wang M; Li Y; Li C; Tang S; Qu X; Feng N; Wu Y
Am J Physiol Endocrinol Metab; 2019 Apr; 316(4):E590-E604. PubMed ID: 30668150
[TBL] [Abstract][Full Text] [Related]
5. Runx1 is a central regulator of osteogenesis for bone homeostasis by orchestrating BMP and WNT signaling pathways.
Tang CY; Wu M; Zhao D; Edwards D; McVicar A; Luo Y; Zhu G; Wang Y; Zhou HD; Chen W; Li YP
PLoS Genet; 2021 Jan; 17(1):e1009233. PubMed ID: 33476325
[TBL] [Abstract][Full Text] [Related]
6. Emodin regulates bone remodeling by inhibiting osteoclastogenesis and stimulating osteoblast formation.
Kim JY; Cheon YH; Kwak SC; Baek JM; Yoon KH; Lee MS; Oh J
J Bone Miner Res; 2014 Jul; 29(7):1541-53. PubMed ID: 25832436
[TBL] [Abstract][Full Text] [Related]
7. IDH2 deficiency increases bone mass with reduced osteoclastogenesis by limiting RANKL expression in osteoblasts.
Lee SH; Lee SH; Lee JH; Park JW; Kim JE
Bone; 2019 Dec; 129():115056. PubMed ID: 31479775
[TBL] [Abstract][Full Text] [Related]
8. Vitamin C Activates Osteoblastogenesis and Inhibits Osteoclastogenesis via Wnt/β-Catenin/ATF4 Signaling Pathways.
Choi HK; Kim GJ; Yoo HS; Song DH; Chung KH; Lee KJ; Koo YT; An JH
Nutrients; 2019 Feb; 11(3):. PubMed ID: 30818817
[TBL] [Abstract][Full Text] [Related]
9. Regulatory mechanisms of osteoblast and osteoclast differentiation.
Katagiri T; Takahashi N
Oral Dis; 2002 May; 8(3):147-59. PubMed ID: 12108759
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor β suppresses osteoblast differentiation via the vimentin activating transcription factor 4 (ATF4) axis.
Lian N; Lin T; Liu W; Wang W; Li L; Sun S; Nyman JS; Yang X
J Biol Chem; 2012 Oct; 287(43):35975-84. PubMed ID: 22952236
[TBL] [Abstract][Full Text] [Related]
11. Osteoporosis regulation by salubrinal through eIF2α mediated differentiation of osteoclast and osteoblast.
He L; Lee J; Jang JH; Sakchaisri K; Hwang J; Cha-Molstad HJ; Kim KA; Ryoo IJ; Lee HG; Kim SO; Soung NK; Lee KS; Kwon YT; Erikson RL; Ahn JS; Kim BY
Cell Signal; 2013 Feb; 25(2):552-60. PubMed ID: 23178987
[TBL] [Abstract][Full Text] [Related]
12. Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development.
Mukherjee A; Rotwein P
Mol Cell Biol; 2012 Jan; 32(2):490-500. PubMed ID: 22064480
[TBL] [Abstract][Full Text] [Related]
13. atf4 promotes β-catenin expression and osteoblastic differentiation of bone marrow mesenchymal stem cells.
Yu S; Zhu K; Lai Y; Zhao Z; Fan J; Im HJ; Chen D; Xiao G
Int J Biol Sci; 2013; 9(3):256-66. PubMed ID: 23494915
[TBL] [Abstract][Full Text] [Related]
14. Nuclear Factor-Kappa B Regulation of Osteoclastogenesis and Osteoblastogenesis.
Boyce BF; Li J; Yao Z; Xing L
Endocrinol Metab (Seoul); 2023 Oct; 38(5):504-521. PubMed ID: 37749800
[TBL] [Abstract][Full Text] [Related]
15. General transcription factor IIA-gamma increases osteoblast-specific osteocalcin gene expression via activating transcription factor 4 and runt-related transcription factor 2.
Yu S; Jiang Y; Galson DL; Luo M; Lai Y; Lu Y; Ouyang HJ; Zhang J; Xiao G
J Biol Chem; 2008 Feb; 283(9):5542-53. PubMed ID: 18171674
[TBL] [Abstract][Full Text] [Related]
16. Psoralen accelerates bone fracture healing by activating both osteoclasts and osteoblasts.
Zhang T; Han W; Zhao K; Yang W; Lu X; Jia Y; Qin A; Qian Y
FASEB J; 2019 Apr; 33(4):5399-5410. PubMed ID: 30702934
[TBL] [Abstract][Full Text] [Related]
17. HOTAIRM1 promotes osteogenic differentiation and alleviates osteoclast differentiation by inactivating the NF-κB pathway.
Ren Y; Zhang K; Wang J; Meng X; Du X; Shi Z; Xue Y; Hong W
Acta Biochim Biophys Sin (Shanghai); 2021 Feb; 53(2):201-211. PubMed ID: 33404645
[TBL] [Abstract][Full Text] [Related]
18. Anabolic and Antiresorptive Modulation of Bone Homeostasis by the Epigenetic Modulator Sulforaphane, a Naturally Occurring Isothiocyanate.
Thaler R; Maurizi A; Roschger P; Sturmlechner I; Khani F; Spitzer S; Rumpler M; Zwerina J; Karlic H; Dudakovic A; Klaushofer K; Teti A; Rucci N; Varga F; van Wijnen AJ
J Biol Chem; 2016 Mar; 291(13):6754-71. PubMed ID: 26757819
[TBL] [Abstract][Full Text] [Related]
19. IGFBP7 acts as a negative regulator of RANKL-induced osteoclastogenesis and oestrogen deficiency-induced bone loss.
Ye C; Hou W; Chen M; Lu J; Chen E; Tang L; Hang K; Ding Q; Li Y; Zhang W; He R
Cell Prolif; 2020 Feb; 53(2):e12752. PubMed ID: 31889368
[TBL] [Abstract][Full Text] [Related]
20. ATF4 promotes bone angiogenesis by increasing VEGF expression and release in the bone environment.
Zhu K; Jiao H; Li S; Cao H; Galson DL; Zhao Z; Zhao X; Lai Y; Fan J; Im HJ; Chen D; Xiao G
J Bone Miner Res; 2013 Sep; 28(9):1870-1884. PubMed ID: 23649506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
